Phase I/II Trial of Temozolomide (TMZ), Motexafin Gadolinium (MGd), and 60 Gy Fractionated Radiation (RT) for Newly Diagnosed Supratentorial Glioblastoma Multiforme (GBM): Final Results of RTOG 0513

PURPOSE: Phase I: to determine the maximum tolerated dose (MTD) of motexafin gadolinium (MGd) given concurrently with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed supratentorial glioblastoma multiforme (GBM). Phase II: to determine whether this combination improved overa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Radiat Oncol Biol Phys
Main Authors: Brachman, David G., Pugh, Stephanie L, Ashby, Lynn S., Thomas, Theresa A., Dunbar, Erin M., Narayan, Samir, Robins, H. Ian, Bovi, Joseph A., Rockhill, Jason K., Won, Minhee, Curran, Walter P.
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4706375/
https://ncbi.nlm.nih.gov/pubmed/25832688
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2014.12.050
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki